Subscribe to our Newsletters !!
Infections pose an everpresent threat to society a
Biotech Fluidics has introduced a durable dual sta
A new COVID-19 variant, BA.3.2, informally called
The sustained tensions between Iran and the United
For a number of years now, healthcare systems glob
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-lo
Gene and cell treatment firm Oxford Biomedica plc said on Monday it had named French pharmaceutical industry veteran Roch Doliveux as its non-official administrator, as it eyes a possibly significant job in delivering coronavirus antibody.
Doliveux, who right now fills in as a non-official chief at Stryker Corp, will take up his job at Oxford from June 24, the organization said.
A week ago, AstraZeneca reported an association with Oxford to make its test COVID-19 immunization as the drugmaker hopes to support its assembling ability to deliver one billion dosages.
